The present invention relates to a preparation method for a compound of Mod.I crystal form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxomethyl)pyridylfuro[2,3-d]pyridazine methanesulfonate (EOC315), crystal form characterizations thereof, and pharmaceutical uses thereof.